| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells
|
Naito, Masayasu
|
|
2012
|
62 |
2 |
p. 347-357
|
artikel
|
| 2 |
CD40 pathway activation reveals dual function for macrophages in human endometrial cancer cell survival and invasion
|
Dumas, Geneviève
|
|
2012
|
62 |
2 |
p. 273-283
|
artikel
|
| 3 |
Chemoimmunotherapy: reengineering tumor immunity
|
Chen, Gang
|
|
2013
|
62 |
2 |
p. 203-216
|
artikel
|
| 4 |
Chemoimmunotherapy: reengineering tumor immunity
|
Chen, Gang
|
|
|
62 |
2 |
p. 203-216
|
artikel
|
| 5 |
Comparative analysis of monocytic and granulocytic myeloid-derived suppressor cell subsets in patients with gastrointestinal malignancies
|
Duffy, Austin
|
|
2012
|
62 |
2 |
p. 299-307
|
artikel
|
| 6 |
DNA methylation at promoter regions of interleukin 1B, interleukin 6, and interleukin 8 in non-small cell lung cancer
|
Tekpli, Xavier
|
|
2012
|
62 |
2 |
p. 337-345
|
artikel
|
| 7 |
Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation
|
Hattar, Katja
|
|
2012
|
62 |
2 |
p. 309-320
|
artikel
|
| 8 |
Identification of a novel HLA-A2-restricted mutated Survivin epitope and induction of specific anti-HCC CTLs that could effectively cross-recognize wild-type Survivin antigen
|
Shen, Han
|
|
2012
|
62 |
2 |
p. 393-403
|
artikel
|
| 9 |
Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporation
|
Hobo, Willemijn
|
|
2012
|
62 |
2 |
p. 285-297
|
artikel
|
| 10 |
Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy
|
Knights, Ashley J.
|
|
2012
|
62 |
2 |
p. 321-335
|
artikel
|
| 11 |
Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo
|
Tongu, Miki
|
|
2012
|
62 |
2 |
p. 383-391
|
artikel
|
| 12 |
MHC-class I-restricted CD4 T cells: a nanomolar affinity TCR has improved anti-tumor efficacy in vivo compared to the micromolar wild-type TCR
|
Soto, Carolina M.
|
|
2012
|
62 |
2 |
p. 359-369
|
artikel
|
| 13 |
Proposed mechanism of off-target toxicity for antibody–drug conjugates driven by mannose receptor uptake
|
Gorovits, Boris
|
|
2012
|
62 |
2 |
p. 217-223
|
artikel
|
| 14 |
Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer
|
Bunt, Stephanie K.
|
|
2012
|
62 |
2 |
p. 225-236
|
artikel
|
| 15 |
T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment
|
Santegoets, Saskia J. A. M.
|
|
|
62 |
2 |
p. 245-256
|
artikel
|
| 16 |
T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment
|
Santegoets, Saskia J. A. M.
|
|
2012
|
62 |
2 |
p. 245-256
|
artikel
|
| 17 |
The antitumor effect of the Toll-like receptor 3 ligand polyinosinic-cytidylic acid as an adjuvant
|
Huang, Yu-Kun
|
|
2012
|
62 |
2 |
p. 237-244
|
artikel
|
| 18 |
The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigen
|
Aldrich, Joel F.
|
|
2012
|
62 |
2 |
p. 371-382
|
artikel
|
| 19 |
Tumor-specific CD4+ T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells
|
Akhmetzyanova, Ilseyar
|
|
2012
|
62 |
2 |
p. 257-271
|
artikel
|
Tijdschrift beschrijving